Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients

Launched by NOUR ALI ABO EL ELAA FRAGHLY · Aug 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called iontophoresis, which uses a small electrical current to help deliver magnesium sulfate to the elbow area. The goal is to see if this treatment can reduce pain, improve muscle strength, and enhance the ability to use the hand for people suffering from lateral epicondylitis, also known as tennis elbow. This condition causes pain on the outer side of the elbow and can make everyday activities challenging.

To be eligible for this trial, participants should be between 20 and 50 years old and have experienced pain on the outside of their elbow for at least four weeks. They need to have tenderness in that area and show positive results on specific tests that check for this condition. However, individuals with certain health issues, recent treatments, or specific injuries to the elbow or surrounding areas may not qualify. Participants in the trial can expect to receive the treatment, and their progress will be monitored to understand the treatment's effectiveness. It's important to know that the trial is currently looking for more volunteers to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Their age will be ranged between 20-50 years with both gender
• • Pain on the lateral side of the elbow for at least 4 weeks
• • Tenderness over the lateral epicondyle
• • At least two positive provocative tests: Mill test and Thomson test
• Exclusion Criteria:
• • • History of injection, surgery, physical therapy in the elbow area in the last 3 months
• • Previous elbow surgery
• • History of radius/ulna fracture
• • History of cervical and shoulder problems
• • Having bilateral symptoms
• • Concomitant medial epicondylitis
• • Malignancy
• • Pregnancy
• • Systemic rheumatologic disease or systemic infection
• • Inserted cardiac pacemaker
• • Presence of coagulation disorders
• • Cognitive dysfunction